HKSE · 2120.HK · HKD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:47 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
Wenzhou Kangning Hospital Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 1.37% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Wenzhou Kangning Hospital Co., Ltd.’s forward annual dividend is HK$0.42 per share, paid semi-annual. The forward yield is 3.61% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Wenzhou Kangning Hospital Co., Ltd.’s next earnings report is currently expected on Apr 1, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Wenzhou Kangning Hospital Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Wenzhou Kangning Hospital Co., Ltd. oversees and manages a broad array of healthcare facilities throughout the People's Republic of China. A core part of its mission involves providing specialized psychiatric care. The company's diverse operations also encompass real estate rental and sales, software development and IT solutions, hospital administration, forensic analysis, general medical provisions, and the retail of pharmaceutical products. Established in 1996, the organization was initially known as Wenzhou City Kangning Psychiatric Rehabilitation Hospital before officially adopting its current name, Wenzhou Kangning Hospital Co., Ltd., in October 2014. Its principal offices are situated in Wenzhou, PRC.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:13 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q4 2022 | Apr 14, 2023 | -HK$0.96 | HK$850.31M+4.53% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$1.56-HK$0.06 (-3.7%)
Honliv Healthcare Management Group Company Limited’s quoted price sits in the lower half of its reported 52-week range, 10.86% below the high.
HK$1.77-HK$0.01 (-0.56%)
CANbridge Pharmaceuticals Inc.’s quoted price sits in the lower half of its reported 52-week range, 49.43% below the high.
HK$2.35-HK$0.14 (-5.43%)
Pak Fah Yeow International Limited’s quoted price sits in the lower half of its reported 52-week range, 13.92% below the high.
HK$2.20HK$0.00 (0.0%)
EuroEyes International Eye Clinic Limited’s quoted price sits in the lower half of its reported 52-week range, 34.33% below the high.
HK$1.37-HK$0.07 (-4.86%)
Kintor Pharmaceutical Limited’s quoted price sits in the lower half of its reported 52-week range, 70.85% below the high.
HK$1.74+HK$0.06 (+3.57%)
Guangdong Kanghua Healthcare Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 23.68% below the high.
HK$3.39-HK$0.02 (-0.44%)
Hospital Corporation of China Limited’s quoted price sits in the lower half of its reported 52-week range, 50.8% below the high.
HK$0.47-HK$0.02 (-4.08%)
China Biotech Services Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 54.81% below the high.
